In high-risk glaucoma suspects, does selective laser trabeculoplasty, compared to a sham procedure, influence progression to perimetric glaucoma.

Flinders University0 个研究点目标入组 400 人开始时间: 2021年3月23日最近更新: 2024年7月8日

适应症

试验速览

暂无简介。

•1. Ability to understand and sign a written informed consent form prior to initiation of study.
•2. Males and females aged > 18 years.
•3. Treatment naive glaucoma suspects or ocular hypertension (IOP>21, but =28 mmHg)
•- Participants who had previously received topical glaucoma medication can undergo a washout period of 6 weeks or more before reviewing their eligibility
•4. Top tertile (high risk) of the PROGRESSA Risk Predictor Algorithm
•5. Open drainage angles on gonioscopy.
•6. May include pseudoexfoliation syndrome.

•1. BCVA < 6/18 (enrolled eye).
•2. Glaucoma (reproducible field loss), current IOP lowering medication, earlier SLT in study eye.
•3. Active treatment for another ophthalmic condition, or participation in another interventional trial
•4. Retinal, optic nerve, or neurological disease causing a visual field defect.
•5. Pigment dispersion syndrome or anterior segment dysgenesis.
•6. Significant cognitive impairment or inability to perform a reliable automated perimetry.
•7. Contraindications to SLT (active uveitis, insufficient view of trabecular meshwork due to narrow drainage angles or PAS).
•8. Symptomatic cataract.

发起方